BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 70287)

  • 1. Serum FSH, LH and prolactin in normal males and patients with prostatic diseases.
    Hammond GL; Kontturi M; Määttälä P; Puukka M; Vihko R
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):129-35. PubMed ID: 70287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of inhibin, prolactin, TSH, LH, and FSH in benign prostatic hypertrophy before and after tumor resection.
    Phadke MA; Vanage GR; Sheth AR
    Prostate; 1987; 10(2):115-22. PubMed ID: 2436203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men.
    Ortega E; Ruiz E; Mendoza MC; Martin-Andres A; Osorio C
    Experientia; 1979 Jun; 35(6):844-5. PubMed ID: 89045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
    Cochran RC; Ewing LL; Niswender GD
    Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection.
    Wu Y; Pan H; Wang WM; Xu D; Zhang L; Gu ZQ; Bai Q; Qi J; Huang HF
    Asian J Androl; 2017; 19(2):230-233. PubMed ID: 26763548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH).
    Bartsch W; Becker H; Pinkenburg FA; Krieg M
    Acta Endocrinol (Copenh); 1979 Apr; 90(4):727-36. PubMed ID: 86267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transurethral prostate resection and transurethral laser prostatectomy on plasma hormone levels.
    Türkölmez K; Bozlu M; Sarica K; Gemalmaz H; Ozdiler E; Gögüş O
    Urol Int; 1998; 61(3):162-7. PubMed ID: 9933837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen, estrogen, and progesterone receptor contents and serum hormone profiles in patients with benign hypertrophy and carcinoma of the prostate.
    Kumar VL; Wadhwa SN; Kumar V; Farooq A
    J Surg Oncol; 1990 Jun; 44(2):122-8. PubMed ID: 1693995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hormonal status of patients with benign prostatic hypertrophy: FSH, LH, TSH and prolactin responses to releasing hormones.
    Hammond GL; Lukkarinen O; Vihko P; Kontturi M; Vihko R
    Clin Endocrinol (Oxf); 1979 Jun; 10(6):545-52. PubMed ID: 89919
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum hormone levels in benign prostatic hyperplasia.
    Sköldefors H; Blomstedt B; Carlström K
    Scand J Urol Nephrol; 1978; 12(2):111-4. PubMed ID: 80820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum prolactin, FSH, LH and testosterone before and after vasectomy in normal men.
    Nikkanen V; Punnonen R
    Arch Androl; 1982 Jun; 8(4):311-3. PubMed ID: 6810776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis.
    Chen SS; Chen KK; Lin AT; Chang YH; Wu HH; Chang LS
    BJU Int; 2002 May; 89(7):710-3. PubMed ID: 11966629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma reproductive hormones in normal and vasectomized Chinese males.
    Peng XS; Li FD; Miao ZR; Ye XM; Wong Y; Hu XZ; Zhong ZZ; Zeng FX; Wu XQ; Lan J
    Int J Androl; 1987 Apr; 10(2):471-9. PubMed ID: 3112029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy].
    Katayama T; Umeda K; Kazama T
    Hinyokika Kiyo; 1986 Nov; 32(11):1584-9. PubMed ID: 2435122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the correlation between FSH, LH and prolactin serum levels.
    Krause W
    Endokrinologie; 1978 May; 72(2):129-35. PubMed ID: 104865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy.
    Harper ME; Peeling WB; Cowley T; Brownsey BG; Phillips ME; Groom G; Fahmy DR; Griffiths K
    Acta Endocrinol (Copenh); 1976 Feb; 81(2):409-26. PubMed ID: 946155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transurethral resection of prostate on plasma hormone levels in benign prostatic hyperplasia.
    Sasagawa I; Nakada T; Suzuki H; Adachi Y; Adachi M
    Br J Urol; 1993 Nov; 72(5 Pt 1):611-4. PubMed ID: 10071547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.